Neural Regeneration Research ›› 2020, Vol. 15 ›› Issue (2): 263-264.doi: 10.4103/1673-5374.265551

Previous Articles     Next Articles

Ependymal cells and multiple sclerosis: proposing a relationship

Dale Hatrock1,2, Nina Caporicci-Dinucci1,2, Jo Anne Stratton1   

  1. 1The Montreal Neurological Institute, McGill University, Montreal, Canada  2Integrated Program in Neuroscience, McGill University, Montreal, Canada
  • Online:2020-02-15 Published:2020-05-25
  • Contact: Jo Anne Stratton, PhD, jo.stratton@mcgill.ca.

PDF

229

Abstract: Multiple sclerosis (MS) currently affects ~2.5 million people worldwide. MS is typically diagnosed in young adults and is usually not fatal, meaning people live long lives with MS. Affected individuals usually suffer from progressive physical and/or cognitive disability, often including fatigue (89.6%), depression (53.9%), memory loss (49.0%), motor or sensory dysfunction (76.4%, 70.4%) and urinary incontinence (50.8%). This disability weighs on patients, loved ones and caretakers, and costs the economy billions of dollars each year.